These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
230 related articles for article (PubMed ID: 10511014)
21. Strategies for pharmacologic treatment of high functioning autism and Asperger syndrome. Towbin KE Child Adolesc Psychiatr Clin N Am; 2003 Jan; 12(1):23-45. PubMed ID: 12512397 [TBL] [Abstract][Full Text] [Related]
22. Psychopharmacological interventions in autism spectrum disorder. Accordino RE; Kidd C; Politte LC; Henry CA; McDougle CJ Expert Opin Pharmacother; 2016; 17(7):937-52. PubMed ID: 26891879 [TBL] [Abstract][Full Text] [Related]
23. Prevalence and patterns of use of psychoactive medicines among individuals with autism in the Autism Society of Ohio. Aman MG; Lam KS; Collier-Crespin A J Autism Dev Disord; 2003 Oct; 33(5):527-34. PubMed ID: 14594332 [TBL] [Abstract][Full Text] [Related]
24. Psychopharmacology in childhood disorders. Wiener JM Psychiatr Clin North Am; 1984 Dec; 7(4):831-43. PubMed ID: 6151651 [TBL] [Abstract][Full Text] [Related]
25. [Clinical report on pharmacological treatment of autism]. Thivierge J Sante Ment Que; 1998; 23(1):85-95. PubMed ID: 9775955 [TBL] [Abstract][Full Text] [Related]
26. Psychopharmacotherapy of Attention Deficit-Hyperactivity Disorder in Children with Comorbid Conditions. Naguy A Pediatr Neurol; 2018 May; 82():7-12. PubMed ID: 29678368 [TBL] [Abstract][Full Text] [Related]
27. The genetics of autism. Muhle R; Trentacoste SV; Rapin I Pediatrics; 2004 May; 113(5):e472-86. PubMed ID: 15121991 [TBL] [Abstract][Full Text] [Related]
28. Psychopharmacologic interventions for repetitive behaviors in autism spectrum disorders. Soorya L; Kiarashi J; Hollander E Child Adolesc Psychiatr Clin N Am; 2008 Oct; 17(4):753-71, viii. PubMed ID: 18775368 [TBL] [Abstract][Full Text] [Related]
29. Psychotropic medication use among children with autism spectrum disorders within the Simons Simplex Collection: are core features of autism spectrum disorder related? Mire SS; Nowell KP; Kubiszyn T; Goin-Kochel RP Autism; 2014 Nov; 18(8):933-42. PubMed ID: 24031086 [TBL] [Abstract][Full Text] [Related]
30. Prolegomenon to the clinical prerequisite: psychopharmacology and the classification of mental disorders. Ban TA Prog Neuropsychopharmacol Biol Psychiatry; 1987; 11(5):527-80. PubMed ID: 2892227 [No Abstract] [Full Text] [Related]
31. Psychiatric comorbidities and use of psychotropic medications in people with autism spectrum disorder in the United States. Houghton R; Ong RC; Bolognani F Autism Res; 2017 Dec; 10(12):2037-2047. PubMed ID: 28963809 [TBL] [Abstract][Full Text] [Related]
32. Also Topiramate might have some benefit in psychopharmacological treatment of autism. Niederhofer H Med Hypotheses; 2008; 70(2):455. PubMed ID: 17656029 [No Abstract] [Full Text] [Related]
33. Oral famotidine: a potential treatment for children with autism. Linday LA Med Hypotheses; 1997 May; 48(5):381-6. PubMed ID: 9185122 [TBL] [Abstract][Full Text] [Related]
34. The role of glutamate and its receptors in autism and the use of glutamate receptor antagonists in treatment. Rojas DC J Neural Transm (Vienna); 2014 Aug; 121(8):891-905. PubMed ID: 24752754 [TBL] [Abstract][Full Text] [Related]
38. Psychopharmacology of aggression in children and adolescents with primary neuropsychiatric disorders: a review of current and potentially promising treatment options. Nevels RM; Dehon EE; Alexander K; Gontkovsky ST Exp Clin Psychopharmacol; 2010 Apr; 18(2):184-201. PubMed ID: 20384430 [TBL] [Abstract][Full Text] [Related]
39. Potential benefits and limits of psychopharmacological therapies in pervasive developmental disorders. Molteni M; Nobile M; Cattaneo D; Radice S; Clementi E Curr Clin Pharmacol; 2014; 9(4):365-76. PubMed ID: 24050744 [TBL] [Abstract][Full Text] [Related]